Troy A. Luster

982 total citations
18 papers, 634 citations indexed

About

Troy A. Luster is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Troy A. Luster has authored 18 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Oncology. Recurrent topics in Troy A. Luster's work include Fibroblast Growth Factor Research (4 papers), Cell death mechanisms and regulation (4 papers) and Phagocytosis and Immune Regulation (4 papers). Troy A. Luster is often cited by papers focused on Fibroblast Growth Factor Research (4 papers), Cell death mechanisms and regulation (4 papers) and Phagocytosis and Immune Regulation (4 papers). Troy A. Luster collaborates with scholars based in United States, Netherlands and Taiwan. Troy A. Luster's co-authors include Philip E. Thorpe, Jin He, Angie Rizzino, Robin Humphreys, Yi Yin, Linda R. Watkins, Jeffrey A. Carrell, K McCormick, Tamara K. Nowling and Jerry L. Klein and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Troy A. Luster

18 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Troy A. Luster United States 12 352 290 195 71 63 18 634
Eric H. Bent United States 6 252 0.7× 196 0.7× 165 0.8× 45 0.6× 78 1.2× 10 525
Nandini Mondal United States 11 380 1.1× 235 0.8× 166 0.9× 66 0.9× 32 0.5× 13 657
Lai Chun Ong Singapore 5 171 0.5× 173 0.6× 297 1.5× 100 1.4× 45 0.7× 5 546
Rama Jasty United States 11 372 1.1× 142 0.5× 141 0.7× 82 1.2× 33 0.5× 18 583
Anja Wimmel Germany 10 405 1.2× 222 0.8× 254 1.3× 51 0.7× 28 0.4× 11 596
Wade Anderson United States 4 284 0.8× 188 0.6× 210 1.1× 91 1.3× 39 0.6× 7 673
Mariano F. Zacarías Fluck Spain 8 176 0.5× 186 0.6× 236 1.2× 87 1.2× 64 1.0× 15 463
Mihalis S. Kariolis United States 8 241 0.7× 398 1.4× 326 1.7× 100 1.4× 36 0.6× 10 692
Torill Høiby Norway 6 318 0.9× 269 0.9× 255 1.3× 100 1.4× 31 0.5× 8 658
Eric J. Gapud United States 11 789 2.2× 151 0.5× 269 1.4× 105 1.5× 79 1.3× 21 959

Countries citing papers authored by Troy A. Luster

Since Specialization
Citations

This map shows the geographic impact of Troy A. Luster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Troy A. Luster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Troy A. Luster more than expected).

Fields of papers citing papers by Troy A. Luster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Troy A. Luster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Troy A. Luster. The network helps show where Troy A. Luster may publish in the future.

Co-authorship network of co-authors of Troy A. Luster

This figure shows the co-authorship network connecting the top 25 collaborators of Troy A. Luster. A scholar is included among the top collaborators of Troy A. Luster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Troy A. Luster. Troy A. Luster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Luster, Troy A., et al.. (2022). Synthesis of diphenyl-(2-thienyl)phosphine, its chalcogenide derivatives and a series of novel complexes of lanthanide nitrates and triflates. Dalton Transactions. 51(23). 9103–9115. 5 indexed citations
2.
Lizotte, Patrick H., Ruey‐Long Hong, Troy A. Luster, et al.. (2018). A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing. Cancer Immunology Research. 6(12). 1511–1523. 69 indexed citations
3.
Lizotte, Patrick H., Troy A. Luster, Megan E. Cavanaugh, et al.. (2018). Abstract 4935: High-throughput immune-oncology screen identifies EGFR inhibitors as potent enhancers of CTL antigen-specific tumor cell killing. Cancer Research. 78(13_Supplement). 4935–4935. 4 indexed citations
4.
Mohamedali, Khalid A., Gang Niu, Troy A. Luster, et al.. (2012). Pharmacodynamics, tissue distribution, toxicity studies and antitumor efficacy of the vascular targeting fusion toxin VEGF121/rGel. Biochemical Pharmacology. 84(11). 1534–1540. 3 indexed citations
5.
Luster, Troy A., Jeffrey A. Carrell, Yun Hee Cho, et al.. (2012). Fusion Toxin BLyS-Gelonin Inhibits Growth of Malignant Human B Cell Lines In Vitro and In Vivo. PLoS ONE. 7(10). e47361–e47361. 10 indexed citations
6.
Huang, Xianming, Dan Ye, Troy A. Luster, & Philip E. Thorpe. (2012). Abstract 4632: Phosphatidylserine-targeting ‘betabodies’ for the treatment of cancer. Cancer Research. 72(8_Supplement). 4632–4632. 1 indexed citations
7.
Luster, Troy A., et al.. (2009). Mapatumumab and lexatumumab induce apoptosis in TRAIL-R1 and TRAIL-R2 antibody-resistant NSCLC cell lines when treated in combination with bortezomib. Molecular Cancer Therapeutics. 8(2). 292–302. 54 indexed citations
8.
Fox, Norma Lynn, Robin Humphreys, Troy A. Luster, Jerry L. Klein, & Gilles Gallant. (2009). Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-1 and receptor-2 agonists for cancer therapy. Expert Opinion on Biological Therapy. 10(1). 1–18. 50 indexed citations
9.
He, Jin, Yi Yin, Troy A. Luster, Linda R. Watkins, & Philip E. Thorpe. (2009). Antiphosphatidylserine Antibody Combined with Irradiation Damages Tumor Blood Vessels and Induces Tumor Immunity in a Rat Model of Glioblastoma. Clinical Cancer Research. 15(22). 6871–6880. 107 indexed citations
10.
He, Jin, Troy A. Luster, & Philip E. Thorpe. (2007). Radiation-Enhanced Vascular Targeting of Human Lung Cancers in Mice with a Monoclonal Antibody That Binds Anionic Phospholipids. Clinical Cancer Research. 13(17). 5211–5218. 75 indexed citations
11.
Luster, Troy A., Jin He, Xianming Huang, et al.. (2006). Plasma Protein β-2-Glycoprotein 1 Mediates Interaction between the Anti-tumor Monoclonal Antibody 3G4 and Anionic Phospholipids on Endothelial Cells. Journal of Biological Chemistry. 281(40). 29863–29871. 57 indexed citations
12.
Luster, Troy A., et al.. (2005). Distal enhancer of the mouse FGF‐4 gene and its human counterpart exhibit differential activity: Critical role of a GT box. Molecular Reproduction and Development. 71(3). 263–274. 2 indexed citations
13.
Ran, Sophia, Khalid A. Mohamedali, Troy A. Luster, Philip E. Thorpe, & Michael G. Rosenblum. (2005). The Vascular-Ablative Agent VEGF121/rGel Inhibits Pulmonary Metastases of MDA-MB-231 Breast Tumors. Neoplasia. 7(5). 486–496. 28 indexed citations
14.
Beck, Adam W., Troy A. Luster, Andrew F. Miller, et al.. (2005). Combination of a monoclonal anti‐phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice. International Journal of Cancer. 118(10). 2639–2643. 65 indexed citations
15.
Luster, Troy A. & Angie Rizzino. (2003). Regulation of the FGF-4 gene by a complex distal enhancer that functions in part as an enhanceosome. Gene. 323. 163–172. 16 indexed citations
16.
Desler, Michelle, et al.. (2002). Effects of B-Myb on Gene Transcription. Journal of Biological Chemistry. 277(6). 4088–4097. 48 indexed citations
17.
Luster, Troy A., et al.. (2001). TRANSCRIPTIONAL REGULATION OF THE TRANSFORMING GROWTH FACTOR-β2 GENE IN GLIOBLASTOMA CELLS. In Vitro Cellular & Developmental Biology - Animal. 37(10). 684–684. 16 indexed citations
18.
Luster, Troy A., et al.. (2000). Effects of three Sp1 motifs on the transcription of the FGF-4 gene. Molecular Reproduction and Development. 57(1). 4–15. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric H. Bent Breakdown of academic impact, for papers by Nandini Mondal Breakdown of academic impact, for papers by Lai Chun Ong Breakdown of academic impact, for papers by Rama Jasty Breakdown of academic impact, for papers by Anja Wimmel Breakdown of academic impact, for papers by Wade Anderson Breakdown of academic impact, for papers by Mariano F. Zacarías Fluck Breakdown of academic impact, for papers by Mihalis S. Kariolis Breakdown of academic impact, for papers by Torill Høiby Breakdown of academic impact, for papers by Eric J. Gapud
Rankless by CCL
2026